Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMS | P04818 | 6/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19129669 | 0.84 | RNASE1 (0.32) | — | |
| SCHEMBL21560996 | 0.82 | TK1 (0.44) | — | |
| SCHEMBL19129852 | 0.80 | RNASE1 (0.36) | POLB | |
| SCHEMBL29456897 | 0.76 | POLB (0.67) | TYMSPOLB | |
| SCHEMBL8529362 | 0.76 | POLB (0.67) | TYMSPOLB | |
| SCHEMBL16130860 | 0.76 | POLB (0.67) | TYMSPOLB | |
| SCHEMBL20987570 | 0.75 | POLB (0.66) | TYMSPOLB | |
| SCHEMBL20987563 | 0.75 | POLB (0.66) | TYMSPOLB | |
| SCHEMBL17231073 | 0.75 | POLB (0.66) | TYMSPOLB | |
| SCHEMBL17231067 | 0.75 | POLB (0.66) | TYMSPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10246479-B2 | Method of preparation of nanopore and uses thereof | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2019-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10246479-B2 | Method of preparation of nanopore and uses thereof | DNTT, NCL, PHAX | TYMS 169/4885POLB 99/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.